Fundraising Fox

ProbiusDX

Fremont, US · Founded 2016 · Delaware corporation · 16 employees on LinkedIn · 6 known investors

Find your way into ProbiusDX

1,211 people in our graph share verified history with the ProbiusDX team — schools, employers, funds. One of them is your warm intro.

Deep Nisharunlockedknows Chaitanya Gupta · together at Stanford University (overlapped)
×10knows the team · via Stanford University
knows the team · via UC Berkeley

Probius develops Quantum Electrochemical Spectroscopy (QES), a label- and reagent-free electrochemical sensing technology that detects and quantifies thousands of analytes—proteins, metabolites, and cells—from microliter-scale biological samples in about 30 minutes. The platform generates digital representations of biological specimens and cloud-based multiplex assays intended to feed AI models of biology for biomarker discovery, drug development, and bioproduction quality control.

Founders & leadership

ProbiusDX was founded in 2016 by Chaitanya Gupta and Emmanuel Quevy.

CG
Chaitanya GuptainCo-founder, CTOCo-founder and CTO of ProbiusDX, which develops electrochemical sensing technology for high-throughput biochemical analysis of biological samples.
EQEmmanuel Quevy
Emmanuel QuevyinCo-Founder and CEOCo-founder and CEO of ProbiusDX, which develops electrochemical sensing technology for detecting and quantifying biological analytes from small-scale samples.

Investors · 6

Reported raises · per SEC filings

Form D private placements

$2.4M disclosed across 1 round · 2025

$2.4MraisedAug 2025 · 21 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Chaitanya GuptaExecutive Officer, Director
  • Emmanuel QuevyExecutive Officer, Director
Offering amount
$25M
Amount sold
$2.4M
Sales commissions
$252K
First sale
Aug 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with ProbiusDX for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does ProbiusDX do?
Probius develops Quantum Electrochemical Spectroscopy (QES), a label- and reagent-free electrochemical sensing technology that detects and quantifies thousands of analytes—proteins, metabolites, and cells—from microliter-scale biological samples in about 30 minutes. The platform generates digital representations of biological specimens and cloud-based multiplex assays intended to feed AI models of biology for biomarker discovery, drug development, and bioproduction quality control.
Who founded ProbiusDX?
ProbiusDX was founded by Chaitanya Gupta, Emmanuel Quevy in 2016.
Who are ProbiusDX's investors?
ProbiusDX's investors include Cota Capital, Heuristic Capital Partners, Qubits Ventures, Silicon Catalyst, Social Starts, TSVC.
How much funding has ProbiusDX raised?
ProbiusDX has disclosed $2.4M raised across 1 round.
Where is ProbiusDX headquartered?
ProbiusDX is headquartered in Fremont, US.